Evidence map›Paper›PMID 22275911›Full record

ArticleFrontiers in microbiology2011

Inhibition of the Plasma-Membrane-Associated Serine Protease Cathepsin G by Mycobacterium tuberculosis Rv3364c Suppresses Caspase-1 and Pyroptosis in Macrophages.

Lia Danelishvili, Jamie L Everman, Michael J McNamara, Luiz E Bermudez

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Structural basis ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Pathogens (Basel, Switzerland) · 2023
    Article
  15. Virulence Factors ofPathogens (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
  18. Frontiers in cellular and infection microbiology · 2023
    Review
  19. The Upregulation ofAnimals : an open access journal from MDPI · 2022
    Article
  20. Different modalities of host cell death and their impact onAmerican journal of physiology. Cell physiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lia DanelishviliDepartment of Biomedical Sciences, College of Veterinary Medicine, Oregon State University Corvallis, OR, USA.
Jamie L Everman
Michael J McNamara
Luiz E Bermudez
Oregon State University · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Post Translation Regulation in MycobacteriaR21AI064018 · NIAID · OREGON STATE UNIVERSITY · PI BERMUDEZ, LUIZ EDUARDO · 2007 to 2008
$399k
NIAID NIH HHS R21 AI064018NIEHS NIH HHS P30 ES000210
6 · The paper itself

Abstract

Tuberculosis is a disease associated with the infection of a great part of the world's population and is responsible for the death of two to three million people annually. Mycobacterium tuberculosis infects macrophages and subverts its mechanisms of killing. The pathogen suppresses macrophage apoptosis by many different mechanisms. We describe that, upon uptake by macrophages, M. tuberculosis overexpresses an operon Rv3361c-Rv3365c and secretes Rv3364c. The Rv3365c knockout strain is deficient in apoptosis inhibition. The Rv3364c protein binds to the serine protease cathepsin G on the membrane, inhibiting its enzymatic activity and the downstream activation of caspase-1-dependent apoptosis. In summary, M. tuberculosis prevents macrophage pyroptosis by a novel mechanism involving cytoplasmic surveillance proteins.

Indexed as

apoptosiscaspase-1-dependentinhibitionmacrophagesMycobacterium tuberculosispyroptosis

Identifiers

PMID22275911
PMCPMC3257866
OpenAlexW2008511309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.